DrugPatentWatch Database Preview
CAROSPIR Drug Profile
Email this page to a colleague
» See Plans and PricingWhich patents cover Carospir, and when can generic versions of Carospir launch?
Carospir is a drug marketed by Cmp Dev Llc and is included in one NDA. There are three patents protecting this drug.
This drug has three patent family members in three countries.
The generic ingredient in CAROSPIR is spironolactone. There are sixteen drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the spironolactone profile page.
US ANDA Litigation and Generic Entry Outlook for Carospir
A generic version of CAROSPIR was approved as spironolactone by SUN PHARM INDUSTRIES on July 23rd, 1986.
Summary for CAROSPIR
| International Patents: | 3 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 74 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,251 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CAROSPIR |
| DailyMed Link: | CAROSPIR at DailyMed |
Recent Clinical Trials for CAROSPIR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mayo Clinic | Phase 2 |
Pharmacology for CAROSPIR
| Drug Class | Aldosterone Antagonist |
| Mechanism of Action | Aldosterone Antagonists |
US Patents and Regulatory Information for CAROSPIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cmp Dev Llc | CAROSPIR | spironolactone | SUSPENSION;ORAL | 209478-001 | Aug 4, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Cmp Dev Llc | CAROSPIR | spironolactone | SUSPENSION;ORAL | 209478-001 | Aug 4, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Cmp Dev Llc | CAROSPIR | spironolactone | SUSPENSION;ORAL | 209478-001 | Aug 4, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for CAROSPIR
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2017075463 | Start Trial |
| European Patent Office | 3368045 | Start Trial |
| Canada | 3003028 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
